Teva Catches A Break On Copaxone 40mg, But For How Long?

An FDA warning letter cites deficiencies at the Pfizer-owned manufacturing facility poised to produce a Momenta/Sandoz generic competitor. It’s unclear how long Pfizer might take to resolve the violations, which include particulates in finished products.

More from Manufacturing

More from Business